Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study.
- Author:
Yong Chon PARK
1
;
Shu Yu YANG
;
Mian Yoon CHONG
;
Shigenobu KANBA
;
Norman SARTORIUS
;
Naotaka SHINFUKU
;
Chay Hoon TAN
;
Seon Cheol PARK
Author Information
- Publication Type:Brief Communication
- Keywords: Asian; Antipsychotic; High dose; Schizophrenia
- MeSH: Asia; Asian Continental Ancestry Group*; Bangladesh; China; Far East; Hong Kong; Humans; India; Indonesia; Japan; Korea; Malaysia; Myanmar; Pakistan; Prescriptions*; Schizophrenia*; Singapore; Sri Lanka; Taiwan; Thailand; Vietnam
- From:Psychiatry Investigation 2018;15(10):1007-1008
- CountryRepublic of Korea
- Language:English
- Abstract: The REAP-AP study recruited 3,746 patients with schizophrenia, in March and April 2016, from 71 centers in 15 Asian countries/territories namely Bangladesh, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, Thailand and Vietnam. Our findings reveal a trend according to which high dose antipsychotic prescription is more prevalent in Eastern Asia (especially, Japan and Korea) than in other regions of Asia. This historical factor may be associated with our finding of an Eastern Asian preponderance of high dose antipsychotic prescription.
